Connect your AI

Nuvation Bio NUVB Proceeds From Revenue Interest Financing Agreement

Proceeds From Revenue Interest Financing Agreement at other companies

Delek US HoldingsDK

$268.6M-25.8%

Calumet, Inc.CLMT

$40M+10.6%

LTC PropertiesLTC

$8.26M+17.9%

Syndax PharmaceuticalsSNDX

$0-100%

Healthcare Realty TrustHR

$3.71M-0.5%

Jackson FinancialJXN

$463M+70.2%

Other financials

Income statement

Revenue$83.2M+2,599%

Gross profit$9.8M+1,340%

Operating income$3.9M+107%

Net income$5.4M+110%

EPS (diluted)$0.01+106%

Balance sheet

Cash & equivalents$125.4M+161%

Total debt$57.2M+401%

Total equity$319.6M-23.8%

Total assets$610.2M+23.9%

Cash flow

Operating cash flow$5.1M+112%

CapEx$48.0K-33.3%

Free cash flow$5.0M+112%

Valuation

Market cap$2.1B+150%

Enterprise value$2.03B+154%

P/S14.7×-62.0×

Profitability

Gross margin54.3%+39.5pp

Operating margin-105%-52.0pp

Net margin-102.1%-50.6pp

FCF margin-93.5%-45.2pp

Returns & leverage

Return on equity-39.5%-15.8pp

Debt / equity0.2×+0.2×

Current ratio7.4×-1.6×

Where this comes from

Reported directly by Nuvation Bio in its filing.

Tagged under the XBRL concept nuvb:ProceedsFromRevenueInterestFinancingAgreement.

The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's proceeds from revenue interest financing agreement.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Nuvation Bio's proceeds from revenue interest financing agreement?: Nuvation Bio (NUVB) reported proceeds from revenue interest financing agreement of $864K in Q1 2026.
What does proceeds from revenue interest financing agreement mean?: Represents cash inflows received from non-dilutive financing arrangements where the company sells a portion of future revenue streams to investors. This metric is critical for biopharmaceutical companies to fund clinical development without immediate equity dilution. It reflects the company's ability to leverage future commercial success to secure current operational capital.